Financial statements Dna Lab W Likwidacji
Balance sheet of Dna Lab W Likwidacji
Share capital:
Share capital:
5 000 PLN
Company deleted from KRS: 2024-10-09
Balance sheet data of DNA LAB W LIKWIDACJI
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 369 613,54 | 346 967,20 |
| A. Fixed assets | 126 123,34 | 111 946,47 |
| B. Current assets | 243 490,20 | 235 020,73 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 369 613,54 | 346 967,20 |
| A. Equity | 257 053,92 | 268 525,48 |
| B. Liabilities and provisions for liabilities | 112 559,62 | 78 441,72 |
| I. Long-term liabilities | - | - |
| II. Short-term liabilities | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.